The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

C. L. Downey; S. A. Simpkins; J. White; D. L. Holliday; J. L. Jones; L. B. Jordan; J. Kulka; S. Pollock; S. S. Rajan; H. H. Thygesen; A. M. Hanby; V Speirs

doi:10.1038/bjc.2014.69

The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

C. L. Downey, S. A. Simpkins, J. White, D. L. Holliday, J. L. Jones, L. B. Jordan, J. Kulka, S. Pollock, S. S. Rajan, H. H. Thygesen, A. M. Hanby, V Speirs

Research output: Contribution to journal › Article › peer-review

56 Citations (Scopus)

4 Downloads (Pure)

Abstract

BACKGROUND: A high percentage of stroma predicts poor survival in triple-negative breast cancers but is diminished in studies of unselected cases. We determined the prognostic significance of tumour-stroma ratio (TSR) in oestrogen receptor (ER)-positive male and female breast carcinomas.

METHODS: TSR was measured in haematoxylin and eosin-stained tissue sections (118 female and 62 male). Relationship of TSR (cutoff 49%) to overall survival (OS) and relapse-free survival (RFS) was analysed.

RESULTS: Tumours with ≥49% stroma were associated with better survival in female (OS P=0.008, HR=0.2-0.7; RFS P=0.006, HR=0.1-0.6) and male breast cancer (OS P=0.005, HR=0.05-0.6; RFS P=0.01, HR=0.87-5.6), confirmed in multivariate analysis.

CONCLUSIONS: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and highlighting the importance of considering ER status when interpreting the prognostic value of TSR.

Original language	English
Pages (from-to)	1744-1747
Number of pages	4
Journal	British Journal of Cancer
Volume	110
Issue number	7
Early online date	18 Feb 2014
DOIs	https://doi.org/10.1038/bjc.2014.69
Publication status	Published - 1 Apr 2014

Keywords

breast cancer
male
stroma
tumour-stroma ratio
prognosis

Access to Document

10.1038/bjc.2014.69Licence: CC BY-NC-SA

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Final published version, 244 KBLicence: CC BY-NC-SA

Fingerprint Dive into the research topics of 'The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Cite this

The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. / Downey, C. L.; Simpkins, S. A.; White, J.; Holliday, D. L.; Jones, J. L.; Jordan, L. B.; Kulka, J.; Pollock, S.; Rajan, S. S.; Thygesen, H. H.; Hanby, A. M.; Speirs, V.

In: British Journal of Cancer, Vol. 110, No. 7, 01.04.2014, p. 1744-1747.

Research output: Contribution to journal › Article › peer-review

@article{beed91a76b3644f2b93b40a1f2939d72,

title = "The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer",

abstract = "BACKGROUND: A high percentage of stroma predicts poor survival in triple-negative breast cancers but is diminished in studies of unselected cases. We determined the prognostic significance of tumour-stroma ratio (TSR) in oestrogen receptor (ER)-positive male and female breast carcinomas.METHODS: TSR was measured in haematoxylin and eosin-stained tissue sections (118 female and 62 male). Relationship of TSR (cutoff 49%) to overall survival (OS) and relapse-free survival (RFS) was analysed.RESULTS: Tumours with ≥49% stroma were associated with better survival in female (OS P=0.008, HR=0.2-0.7; RFS P=0.006, HR=0.1-0.6) and male breast cancer (OS P=0.005, HR=0.05-0.6; RFS P=0.01, HR=0.87-5.6), confirmed in multivariate analysis.CONCLUSIONS: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and highlighting the importance of considering ER status when interpreting the prognostic value of TSR.",

keywords = "breast cancer, male, stroma, tumour-stroma ratio, prognosis",

author = "Downey, {C. L.} and Simpkins, {S. A.} and J. White and Holliday, {D. L.} and Jones, {J. L.} and Jordan, {L. B.} and J. Kulka and S. Pollock and Rajan, {S. S.} and Thygesen, {H. H.} and Hanby, {A. M.} and V Speirs",

note = "We are grateful to Breast Cancer Campaign for funding our collection of male breast carcinomas and for supporting DLH and SP. SAS was funded by the Wolfson Foundation and a Wellcome Trust Vacation Scholarship. HHT was funded by Cancer Research UK. We convey special thanks to members of the Leeds Breast Team for input and support at various stages of this project.",

year = "2014",

month = apr,

day = "1",

doi = "10.1038/bjc.2014.69",

language = "English",

volume = "110",

pages = "1744--1747",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer

AU - Downey, C. L.

AU - Simpkins, S. A.

AU - White, J.

AU - Holliday, D. L.

AU - Jones, J. L.

AU - Jordan, L. B.

AU - Kulka, J.

AU - Pollock, S.

AU - Rajan, S. S.

AU - Thygesen, H. H.

AU - Hanby, A. M.

AU - Speirs, V

N1 - We are grateful to Breast Cancer Campaign for funding our collection of male breast carcinomas and for supporting DLH and SP. SAS was funded by the Wolfson Foundation and a Wellcome Trust Vacation Scholarship. HHT was funded by Cancer Research UK. We convey special thanks to members of the Leeds Breast Team for input and support at various stages of this project.

PY - 2014/4/1

Y1 - 2014/4/1

N2 - BACKGROUND: A high percentage of stroma predicts poor survival in triple-negative breast cancers but is diminished in studies of unselected cases. We determined the prognostic significance of tumour-stroma ratio (TSR) in oestrogen receptor (ER)-positive male and female breast carcinomas.METHODS: TSR was measured in haematoxylin and eosin-stained tissue sections (118 female and 62 male). Relationship of TSR (cutoff 49%) to overall survival (OS) and relapse-free survival (RFS) was analysed.RESULTS: Tumours with ≥49% stroma were associated with better survival in female (OS P=0.008, HR=0.2-0.7; RFS P=0.006, HR=0.1-0.6) and male breast cancer (OS P=0.005, HR=0.05-0.6; RFS P=0.01, HR=0.87-5.6), confirmed in multivariate analysis.CONCLUSIONS: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and highlighting the importance of considering ER status when interpreting the prognostic value of TSR.

AB - BACKGROUND: A high percentage of stroma predicts poor survival in triple-negative breast cancers but is diminished in studies of unselected cases. We determined the prognostic significance of tumour-stroma ratio (TSR) in oestrogen receptor (ER)-positive male and female breast carcinomas.METHODS: TSR was measured in haematoxylin and eosin-stained tissue sections (118 female and 62 male). Relationship of TSR (cutoff 49%) to overall survival (OS) and relapse-free survival (RFS) was analysed.RESULTS: Tumours with ≥49% stroma were associated with better survival in female (OS P=0.008, HR=0.2-0.7; RFS P=0.006, HR=0.1-0.6) and male breast cancer (OS P=0.005, HR=0.05-0.6; RFS P=0.01, HR=0.87-5.6), confirmed in multivariate analysis.CONCLUSIONS: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and highlighting the importance of considering ER status when interpreting the prognostic value of TSR.

KW - breast cancer

KW - male

KW - stroma

KW - tumour-stroma ratio

KW - prognosis

U2 - 10.1038/bjc.2014.69

DO - 10.1038/bjc.2014.69

M3 - Article

C2 - 24548861

VL - 110

SP - 1744

EP - 1747

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 7

ER -